Presentation is loading. Please wait.

Presentation is loading. Please wait.

Solitaire FR Revascularization Device™ Jeffrey McCarthy BME181 University of Rhode Island.

Similar presentations


Presentation on theme: "Solitaire FR Revascularization Device™ Jeffrey McCarthy BME181 University of Rhode Island."— Presentation transcript:

1 Solitaire FR Revascularization Device™ Jeffrey McCarthy BME181 University of Rhode Island

2 Objectives Review the symptoms of a stroke Discuss why strokes occur Describe the use of the Solitaire device to treat a stroke

3 Symptoms of Stroke

4 What Causes a Stroke?

5 Treatment Options for Stroke Time from symptom onset – < 3 or < 4.5 hours – “clot buster” medication tPA (Alteplase) – Greater than 4.5 hours OR ineligible for tPA Mechanical thrombectomy – Up to 8 hours from symptom onset

6 Finding the Clot Normal AngiographyAngiography showing a Stroke

7 Solitaire in Action

8 Solitaire Device TS5Y TS5Y

9 Effectiveness of Solitaire Device SWIFT TRIAL Solitaire DeviceMerci Retriever Recanalization Rates 61%24% Good Neurological Outcomes at 90 Days 58%33% 90 Day Mortality17%38%

10 1.)“Solitaire FR Revascularization Device” Covidien. 27 Feb )Saver, JL Jahon R, Levy EI. Solitaire flow restoration device versus the Merci Retreiver in patients with acute ischaemic stroke (SWIFT): a randomized, parallel-group, non-inferiority trial. The Lancet, 380(9849), )“About Stroke” American Stroke Association. 27 Feb References:


Download ppt "Solitaire FR Revascularization Device™ Jeffrey McCarthy BME181 University of Rhode Island."

Similar presentations


Ads by Google